Vertex to Acquire Crinetics Pharmaceuticals

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

The Only 2 External BDCs I Own - And Plan To Hold For Decades

Learn why externally managed BDCs face fee headwinds, which 2 passed my durable income test, and the key criteria I used—read ...

Nebius: Why I'm Buying The Meta Compute Panic

Nebius is a Strong Buy, reiterating 3.5GW contracted power, a 4GW target, and continued supply-constrained demand. Read more ...

Vertex Pharmaceuticals Incorporated and Crinetics Pharmaceuticals, Inc.: Vertex to Acquire Crinetics Pharmaceuticals

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...